Ascendis Pharma A/S Adjustments For Decrease Increase In Trade Account Receivable
Ascendis Pharma A/S (ASND) reported Adjustments For Decrease Increase In Trade Account Receivable of EUR 797.00 thousand for the 3-month period ending 2020-03-31, per its 6-K filed 2020-05-19.
Discontinued › Notes › Receivables
ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAccountReceivable · last filed 2020-05-19
- Ascendis Pharma A/S adjustments for decrease increase in trade account receivable for the quarter ending 2020-03-31 was 797.00K EUR.
- Ascendis Pharma A/S adjustments for decrease increase in trade account receivable for the quarter ending 2019-09-30 was 0.00 EUR.
- Ascendis Pharma A/S adjustments for decrease increase in trade account receivable for the quarter ending 2019-06-30 was 5.20M EUR, a 30494.12% increase year-over-year.
- Ascendis Pharma A/S adjustments for decrease increase in trade account receivable for the quarter ending 2019-03-31 was -5.20M EUR, a 3473.38% decline year-over-year.
| Period end | Adjustments For Decrease Increase In Trade Account Receivable 3 month | Adjustments For Decrease Increase In Trade Account Receivable 3 month as first filed | Adjustments For Decrease Increase In Trade Account Receivable 6 month | Adjustments For Decrease Increase In Trade Account Receivable 9 month | Adjustments For Decrease Increase In Trade Account Receivable 12 month |
|---|---|---|---|---|---|
| 2020-03-31 | 797.00K EUR 6-K · filed 2020-05-19 | ||||
| 2019-09-30 | 0.00 EUR derived: 6-K 9 month − 6-K 6 month · filed 2019-11-18 | 5.20M EUR derived: sum of 2 quarters · filed 2019-11-18 | 6.00K EUR 6-K · filed 2019-11-18 | 21.00K EUR derived: sum of 4 quarters · filed 2020-05-19 | |
| 2019-06-30 | 5.20M EUR derived: 6-K 6 month − 6-K 3 month · filed 2019-08-28 | 6.00K EUR 6-K · filed 2019-08-28 | 21.00K EUR derived: sum of 3 quarters · filed 2020-05-19 | 17.00K EUR derived: sum of 4 quarters · filed 2020-05-19 | |
| 2019-03-31 | -5.20M EUR 6-K · filed 2020-05-19 | 2.00K EUR 6-K · filed 2019-05-30 | -5.18M EUR derived: sum of 2 quarters · filed 2020-05-19 | -5.18M EUR derived: sum of 3 quarters · filed 2020-05-19 | -5.17M EUR derived: sum of 4 quarters · filed 2020-05-19 |
| 2018-12-31 | 15.00K EUR derived: 20-F 12 month − 6-K 9 month · filed 2019-04-03 | 11.00K EUR derived: sum of 2 quarters · filed 2019-11-18 | 28.00K EUR derived: sum of 3 quarters · filed 2019-11-18 | 182.00K EUR 20-F · filed 2019-04-03 | |
| 2018-09-30 | -4.00K EUR derived: 6-K 9 month − 6-K 6 month · filed 2019-11-18 | 13.00K EUR derived: sum of 2 quarters · filed 2019-11-18 | 167.00K EUR 6-K · filed 2019-11-18 | 423.00K EUR derived: sum of 4 quarters · filed 2019-11-18 | |
| 2018-06-30 | 17.00K EUR derived: 6-K 6 month − 6-K 3 month · filed 2019-08-28 | 171.00K EUR 6-K · filed 2019-08-28 | 427.00K EUR derived: sum of 3 quarters · filed 2019-08-28 | 433.00K EUR derived: sum of 4 quarters · filed 2019-08-28 | |
| 2018-03-31 | 154.00K EUR 6-K · filed 2019-05-30 | 410.00K EUR derived: sum of 2 quarters · filed 2019-05-30 | 416.00K EUR derived: sum of 3 quarters · filed 2019-05-30 | 344.00K EUR derived: sum of 4 quarters · filed 2019-05-30 | |
| 2017-12-31 | 256.00K EUR derived: 20-F 12 month − 6-K 9 month · filed 2019-04-03 | 262.00K EUR derived: sum of 2 quarters · filed 2019-04-03 | 190.00K EUR derived: sum of 3 quarters · filed 2019-04-03 | 99.00K EUR 20-F · filed 2019-04-03 | |
| 2017-09-30 | 6.00K EUR derived: 6-K 9 month − 6-K 6 month · filed 2018-11-28 | -66.00K EUR derived: sum of 2 quarters · filed 2018-11-28 | -157.00K EUR 6-K · filed 2018-11-28 | ||
| 2017-06-30 | -72.00K EUR derived: 6-K 6 month − 6-K 3 month · filed 2018-08-29 | -163.00K EUR 6-K · filed 2018-08-29 | |||
| 2017-03-31 | -91.00K EUR 6-K · filed 2018-05-30 | ||||
| 2016-12-31 | 777.00K EUR 20-F · filed 2019-04-03 | ||||
| 2015-12-31 | 228.00K EUR 20-F · filed 2018-03-28 |